Current clinical perspectives on targeted therapy and immunotherapy for melanoma - European Medical Journal

Continue

Current clinical perspectives on targeted therapy and immunotherapy for melanoma

Oncology
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Caroline Robert, MD, PhD, of Institut Gustave Roussy, Villejuif, France, considers the impact of available and emerging targeted therapies and immunotherapies on the current treatment landscape in melanoma.

Rate this content's potential impact on patient outcomes

Thank you!

Please share some more information on the rating you have given